Why is Godavari Drugs falling/rising?

As of 30-Jul, Godavari Drugs Ltd is experiencing a price increase, currently at Rs 85.49, reflecting a rise of Rs 1.48 or 1.76%. Today's performance indicates a trend reversal, as the stock has gained after two consecutive days of decline. It opened with a gain of 2.37% and reached an intraday high of Rs 86. Additionally, the stock has outperformed its sector by 1.42%. However, despite this short-term gain, the stock has shown a negative return of -16.39% over the past year, and its profits have decreased by -22.1%. The company has a high Debt to EBITDA ratio of 3.15 times, indicating a low ability to service debt, which contributes to its weak long-term fundamental strength. In the broader market context, Godavari Drugs' short-term performance contrasts with the benchmark, as it has declined by -4.80% over the past week while the Sensex has only fallen by -1.50%. This underperformance is notable given that the stock has also shown a significant decline of -21.82% year-to-date, compared to the Sensex's positive return of +4.28%. The stock's liquidity is adequate, with a delivery volume increase of 14.68% against the five-day average, suggesting some investor interest despite its overall poor performance in the longer term.